News | 07 September 2026
Morepen completes 1st phase of manufacturing capacity expansion program
The company's installed reactor capacity for API and CDMO has increased from 535 KL to 614 KL
The company's installed reactor capacity for API and CDMO has increased from 535 KL to 614 KL
The acquired portfolio includes Minipress XL (prazosin)
This decision follows a directive by Pfizer Inc. USA to cease the global manufacturing of the product
The company is committing Rs. 40–50 crore towards a dedicated custom peptide capacity programme through a strategic capacity underwriting arrangement
The partnership expands Tech Mahindra’s healthcare and life sciences business in North America and strengthens its positioning as a technology transformation partner for healthcare providers
The launch represents a significant expansion of the company’s business interests and comes as pharmaceutical companies increasingly seek opportunities across emerging and international markets
The deal gives Gan & Lee a major European partner as the Chinese pharmaceutical company seeks to turn bofanglutide into a global metabolic-health product
ZPUI has agreed to pay a total of US$ 5.9 million to resolve above litigation matters
The transaction marks RPGAP’s second strategic acquisition following its recent acquisition of Actis Generics
Priority-reviewed topical JAK inhibitor now approved for children as young as two, backed by Phase III data showing 63% response rate at eight weeks
The analysis is based on diagnostic testing trends across its network and tracks changes in disease positivity and geographic patterns
The completion of the Apogee acquisition is an important step in further strengthening AbbVie's leadership in immunology and advancing our long-term growth strategy
The certification was issued following an audit by SGS, an independent testing, inspection and certification company, and covers the facility’s commercial-scale production of QS-21
The campaign combines Fortis Healthcare’s clinical expertise and hospital network with Takeda’s scientific expertise in dengue prevention and public health education
The discussions will examine how quality systems can move beyond compliance to become more predictive, risk-based and capable of learning from manufacturing experience
The collaboration is aimed at accelerating some of the most time-intensive regulatory work in drug development
The report examines how changing cultural attitudes toward beauty and aging are reshaping the aesthetic treatment landscap
SkinMedica says Barrier Calming Cream improved skin barrier support and reduced skin dryness by 30% after two weeks
Nod as first new frontline regimen in more than a decade
Subscribe To Our Newsletter & Stay Updated
